Breakthrough T1D Celebrates Tezeild Approval in the EU
January 12, 2026
January 12, 2026
NEW YORK, Jan. 12 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
Breakthrough T1D Celebrates Tezeild Approval in the EU
*
Breakthrough T1D is pleased that the European Commission has approved Tezeild (Tzield in the U.S.) to delay the onset of stage 3 type 1 diabetes (T1D) in individuals with stage 2 T1D who are eight years of age and older. The approval re . . .
* * *
Breakthrough T1D Celebrates Tezeild Approval in the EU
*
Breakthrough T1D is pleased that the European Commission has approved Tezeild (Tzield in the U.S.) to delay the onset of stage 3 type 1 diabetes (T1D) in individuals with stage 2 T1D who are eight years of age and older. The approval re . . .